Diagnocode consisted with L-DNA tested for the ability to hybridize with different concentrations of an oligonucleotide sequence from the breast cancer-specific enhancer zeste homolog 2 (EZH2, CAGATTTCTTCCCAGTCTGGC). The gene discussed is EZH2; the disease is breast cancer.